A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients
Clinical trial NCT02476019 · COMPLETED
Trial details
- NCT number
- NCT02476019
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-07-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.